Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aptiv PLC (APTV) vs BioNano Genomics Inc (BNGO) Price & Performance

BioNano Genomics IncTrade

Price performance (Past 24H)

Key statistics

Aptiv PLC vs BioNano Genomics Inc — how do they compare? Aptiv PLC trades at $50.28 (market cap $10.30B), while BioNano Genomics Inc trades at $1.2 (market cap $13.66M). The key difference: Aptiv PLC is far larger — about 754× BioNano Genomics Inc's market cap. Which is the better fit depends on your goals.

APTVBNGO
Market Cap
$10.30B$13.66M
Sector
Consumer CyclicalHealth
52-Week High
$76.82$4.92
52-Week Low
$46.30$1.06
Enterprise Value
$15.23B$16.26M

Returns comparison

Trailing returns across standard periods

About Aptiv PLC

Aptiv's signal and power solutions segment supplies components and systems that make up a vehicle's electrical system backbone, including wiring assemblies and harnesses, connectors, electrical centers, and hybrid electrical systems. The advanced safety and user experience segment provides body controls, infotainment and connectivity systems, passive and active safety electronics, advanced driver-assist technologies, and displays, as well as the development of software for these systems. Aptiv's largest customer is General Motors at roughly 12% of 2021 revenue, including sales to GM's Shanghai joint venture, followed by Stellantis at 11%, and Volkswagen at 9%. North America and Europe represented approximately 38% and 33% of total 2019 revenue, respectively.

Read more on APTV

About BioNano Genomics Inc

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

Read more on BNGO